Annual report pursuant to Section 13 and 15(d)

Quarterly Financial Data (Unaudited) (Tables)

v3.8.0.1
Quarterly Financial Data (Unaudited) (Tables)
12 Months Ended
Mar. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Summary of Company's Unaudited Quarterly Results

A capsule summary of the Company's unaudited quarterly results for fiscal 2018 and fiscal 2017 is presented below:

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

Year ended March 31, 2018

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

Net sales

 

$

20,851

 

 

$

17,224

 

 

$

17,281

 

 

$

22,178

 

 

$

77,534

 

Gross profit

 

 

4,866

 

 

 

3,830

 

 

 

3,585

 

 

 

5,049

 

 

 

17,330

 

Net (loss) income

 

 

935

 

 

 

10

 

(1)

 

(11,622

)

(1)

 

833

 

(1)

 

(9,844

)

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.10

 

 

$

 

 

$

(1.19

)

 

$

.09

 

 

$

(1.01

)

Diluted

 

$

.10

 

 

$

 

 

$

(1.19

)

 

$

.09

 

 

$

(1.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$19.31-24.03

 

 

$18.78-21.25

 

 

$17.97-22.53

 

 

$19.76-23.25

 

 

$17.97-24.03

 

 

 

 

First

 

 

Second

 

 

Third

 

 

Fourth

 

 

Total

 

 

Year ended March 31, 2017

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Quarter

 

 

Year

 

 

Net sales

 

$

22,365

 

 

$

21,126

 

 

$

22,654

 

 

$

25,624

 

 

$

91,769

 

 

Gross profit

 

 

4,111

 

 

 

5,010

 

 

 

6,301

 

 

 

6,739

 

 

 

22,161

 

 

Net income

 

 

85

 

(2)

 

1,297

 

(2)

 

1,840

 

 

 

1,801

 

 

 

5,023

 

 

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

.01

 

 

$

.13

 

 

$

.19

 

 

$

.18

 

 

$

0.52

 

 

Diluted

 

$

.01

 

 

$

.13

 

 

$

.19

 

 

$

.18

 

 

$

0.52

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market price range of common stock

 

$17.11-19.92

 

 

$17.72-21.09

 

 

$17.19-24.05

 

 

$21.64-24.99

 

 

$17.11-24.99

 

 

 

(1)  In the second quarter of fiscal 2018, the Company recognized restructuring charges of $316.  As a result, net income in the second quarter includes the restructuring charge net of an income tax benefit of $92.  In the third quarter of fiscal 2018, the Company recorded a loss from the impairment of goodwill and intangible assets of $14,816, other charges related to the commercial nuclear business of $280 and an income tax benefit related to the Tax Act.  As a result, net income in the third quarter of fiscal 2018 includes the impairment loss net of an income tax benefit of $2,802, other charges related to the commercial nuclear business net of an income tax benefit of $87 and an income tax benefit of $577 related to the Tax Act.  In the fourth quarter of fiscal 2018, an additional income tax benefit of $209 was recorded related to the Tax Act.  

 

(2)  In the first and second quarters of fiscal 2017, the Company recognized restructuring charges of $555 and $75, respectively.  As a result, net income in the first and second quarters of fiscal 2017 includes the restructuring charge net of an income tax benefit of $172 and $17, respectively.